Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,719 public trials 1,764 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

NCT06545942

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Investigative Site #108 Goodyear, Arizona, United States
  • Investigative Site #101 La Jolla, California, United States
  • Investigative Site #111 San Francisco, California, United States
  • Investigative Site #104 Lake Mary, Florida, United States
View all 18 locations
View Trial Details
Recruiting

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

NCT07524322

Conditions
Adnexal Diseases, Advanced Breast Cancer, Breast Cancer, +30 more
Locations
  • START Los Angeles Los Angeles, California, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Houston Houston, Texas, United States
  • NEXT San Antonio San Antonio, Texas, United States
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

NCT07318805

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +19 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • START Midwest, LLC Grand Rapids, Michigan, United States
  • Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy Long Island City, New York, United States
  • Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). New York, United States
View all 13 locations
View Trial Details
Recruiting

Minimally Interventional Study on Prevalence of Emerging ESR1 Mutations in Liquid Biopsy in Three Cohorts of Patients With Breast Cancer in Comparison With Patient's Baseline ESR1 Mutation Status as Defined by Tissue Profiling.

NCT06417801

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Ensino E Terapia de Inovação Clínica Amo - Ética Salvador, Estado de Bahia, Brazil
  • Irmandade Da Santa Casa de Misericórdia de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil
  • Fundação Antonio Prudente - A.C. Camargo Cancer Center São Paulo, Brazil
  • Instituto D'Or de Pesquisa E Ensino - São Paulo São Paulo, Brazil
View Trial Details

Related conditions